---
figid: PMC7369353__gr1
figtitle: Main mechanisms of Wnt/Beta-catenin and PI3K/AKT/mTORC1 pathway interconnections
organisms:
- NA
pmcid: PMC7369353
filename: gr1.jpg
figlink: pmc/articles/PMC7369353/figure/fig1/
number: F1
caption: Main mechanisms of Wnt/β-catenin and PI3K/AKT/mTORC1 pathway interconnections.
  (A) The Wnt/β-catenin pathway modulates transcription through β-catenin and translation
  via mTORC1 regulating GSK3β activity. (Bi) mTORC1 inhibition by the rapalog everolimus
  induces Wnt/β-catenin signaling activation by increasing the expression of FZD receptor
  levels with a mechanism dependent on DVL. (Bii) Activated mTORC1 promotes the association
  between DVL and the clathrin Adaptor protein 2 (AP-2) adaptor with a consequent
  reduction of FZD expression levels, with a negative regulation of Wnt/β-catenin
  signaling. (C) Wnt/β-catenin signaling switches off the mTORC1 cascade by inducing
  its negative regulator DEPTOR. (D) Inhibited PI3K/AKT/mTORC1 pathway leads to increased
  eIF4E phosphorylation via MNK. Phosphorylated eIF4E is associated with β-catenin
  nuclear translocation and signaling activation. β-CAT, β-catenin; β-TRCP, Beta-transducin
  repeat containing E3 ubiquitin protein ligase.
papertitle: Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal
  Cancer?.
reftext: Anna Prossomariti, et al. Cell Mol Gastroenterol Hepatol. 2020;10(3):491-506.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9463878
figid_alias: PMC7369353__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7369353__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7369353__gr1.html
  '@type': Dataset
  description: Main mechanisms of Wnt/β-catenin and PI3K/AKT/mTORC1 pathway interconnections.
    (A) The Wnt/β-catenin pathway modulates transcription through β-catenin and translation
    via mTORC1 regulating GSK3β activity. (Bi) mTORC1 inhibition by the rapalog everolimus
    induces Wnt/β-catenin signaling activation by increasing the expression of FZD
    receptor levels with a mechanism dependent on DVL. (Bii) Activated mTORC1 promotes
    the association between DVL and the clathrin Adaptor protein 2 (AP-2) adaptor
    with a consequent reduction of FZD expression levels, with a negative regulation
    of Wnt/β-catenin signaling. (C) Wnt/β-catenin signaling switches off the mTORC1
    cascade by inducing its negative regulator DEPTOR. (D) Inhibited PI3K/AKT/mTORC1
    pathway leads to increased eIF4E phosphorylation via MNK. Phosphorylated eIF4E
    is associated with β-catenin nuclear translocation and signaling activation. β-CAT,
    β-catenin; β-TRCP, Beta-transducin repeat containing E3 ubiquitin protein ligase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CACNA1E
  - MTOR
  - RPTOR
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - TSC2
  - LRP6
  - LRP5
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - APC
  - PROC
  - TFAP2A
  - CHKA
  - AXIN1
  - GSK3B
  - BTRC
  - MYC
  - CCND1
  - AXIN2
  - TCF4
  - TCF7L2
  - BLNK
  - MKNK2
  - MKNK1
  - DEPTOR
  - EIF4E
  - EIF4E2
  - EIF4E3
  - Everolimus
  - Rapamycin
---
